L Glass-Marmor1, H Morgenstern, R Beitner
1Department of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.
Four calmodulin antagonists reduced key glycolysis molecules and ATP in B16 melanoma cells, leading to decreased cell viability. These findings highlight potential cancer treatments targeting both proliferation and energy production.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: